InDex Pharmaceuticals’ investor call at 15:00 CET on June 1
STOCKHOLM, May 31, 2023 /PRNewswire/ — InDex Pharmaceuticals Holding AB (publ) will hold an investor call in light of today’s press release announcing the company’s license agreement. The investor call will take place on June 1, 2023 at 15:00 CET via MS Teams. The investor call will be hosted by CEO Jenny Sundqvist and Deputy … Read more